Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03712189 · ClinicalTrials.gov registry record · NA
LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03712189 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 30 participants.
The verdict
NCT03712189, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.
Interventions
- DEVICE LifeFlow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03712189
The ClinicalTrials.gov registry entry for NCT03712189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LifeFlow is the first listed.
NCT03712189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03712189 about?
NCT03712189 is a clinical study titled "LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound". This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.
What is the current status of trial NCT03712189?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-10-02. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03712189?
The interventions under investigation include: LifeFlow (DEVICE).
Who is sponsoring clinical trial NCT03712189?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.